Published in FEBS Lett on December 15, 1986
cDNA sequences of Torpedo marmorata acetylcholinesterase: primary structure of the precursor of a catalytic subunit; existence of multiple 5'-untranslated regions. EMBO J (1987) 1.30
Complex alternative splicing of acetylcholinesterase transcripts in Torpedo electric organ; primary structure of the precursor of the glycolipid-anchored dimeric form. EMBO J (1988) 1.29
Different diurnal cycles of expression of two nitrate reductase transcripts in tobacco roots. Protoplasma (2001) 0.75
Molecular characterization of the human beta 3-adrenergic receptor. Science (1989) 4.13
The molecular forms of cholinesterase and acetylcholinesterase in vertebrates. Annu Rev Neurosci (1982) 3.07
Molecular and cellular biology of cholinesterases. Prog Neurobiol (1993) 3.01
A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet (1998) 2.68
Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest (1993) 2.16
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the delta subunit is labeled by [3H]chlorpromazine. Proc Natl Acad Sci U S A (1986) 2.06
Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med (1995) 1.99
Overweight concerns and body dissatisfaction among third-grade children: the impacts of ethnicity and socioeconomic status. J Pediatr (2001) 1.95
Amino acid sequence of flagellin of Bacillus subtilis 168. III. Tryptic peptides, N-bromosuccinimide peptides, and the complete amino acid sequence. J Biol Chem (1976) 1.92
Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology (1999) 1.90
Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med (1995) 1.88
Complete amino acid sequence and maturation of the mouse submaxillary gland renin precursor. Nature (1982) 1.83
Anti-alprenolol anti-idiotypic antibodies bind to beta-adrenergic receptors and modulate catecholamine-sensitive adenylate cyclase. Proc Natl Acad Sci U S A (1980) 1.80
Amino acids of the Torpedo marmorata acetylcholine receptor alpha subunit labeled by a photoaffinity ligand for the acetylcholine binding site. Biochemistry (1988) 1.80
A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet (2001) 1.79
A rabbit with the allotypic phenotype: ala2a3 b4b5b6. J Immunol (1974) 1.77
Amino acid analysis at the picomole level. Application to the C-terminal sequence analysis of polypeptides. Biochem J (1981) 1.76
The human beta 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci (1994) 1.76
Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol (2001) 1.75
Internalization of beta-adrenergic receptor in A431 cells involves non-coated vesicles. Eur J Cell Biol (1989) 1.71
Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J (1991) 1.65
Active-site catalytic efficiency of acetylcholinesterase molecular forms in Electrophorus, torpedo, rat and chicken. Eur J Biochem (1978) 1.62
Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization. Proc Natl Acad Sci U S A (1987) 1.62
Role for tissue factor pathway in murine model of vascular remodeling. Circ Res (2001) 1.60
ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol (1998) 1.56
Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J Cell Physiol (1994) 1.55
Liquid chromatographic determination of amino acids after gas-phase hydrolysis and derivatization with (dimethylamino)azobenzenesulfonyl chloride. Anal Chem (1986) 1.52
Chromophoric labeling of amino acids with 4-dimethylaminoazobenzene-4'-sulfonyl chloride. Anal Chem (1975) 1.50
Transcranial Doppler assessment of cerebral flow velocity during cognitive tasks. Stroke (1992) 1.49
Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J Biol Chem (1994) 1.46
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Addition of aprotinin to organ preservation solutions decreases lung reperfusion injury. Ann Thorac Surg (1998) 1.40
Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate. Eur J Biochem (1985) 1.37
Evidence for reversible microclustering of lentil lectin membrane receptors on HeLa cells. FEBS Lett (1980) 1.34
Herpes simplex virus gene expression in neurons: viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways. J Virol (1996) 1.32
Characterization of the subunits of the flagella of Proteus vulgaris. J Biol Chem (1969) 1.31
The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol Pharmacol (1993) 1.31
Asymmetric and globular forms of acetylcholinesterase in mammals and birds. Proc Natl Acad Sci U S A (1979) 1.30
Complex alternative splicing of acetylcholinesterase transcripts in Torpedo electric organ; primary structure of the precursor of the glycolipid-anchored dimeric form. EMBO J (1988) 1.29
Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic). Am J Hum Genet (1998) 1.29
Evidence for a functional beta 3-adrenoceptor in man. Br J Pharmacol (1993) 1.27
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. Br J Cancer (2004) 1.27
Manual micro-sequence analysis of polypeptides using dimethylaminoazobenzene isothiocyanate. Methods Enzymol (1983) 1.26
The human carcinoma cell line A431 possesses large numbers of functional beta-adrenergic receptors. FEBS Lett (1984) 1.25
H and T subunits of acetylcholinesterase from Torpedo, expressed in COS cells, generate all types of globular forms. J Cell Biol (1992) 1.24
Amino acid analysis in the picomole range by precolumn derivatization and high-performance liquid chromatography. Methods Enzymol (1983) 1.24
Comparison of the N-terminal sequences of aspartate and ornithine carbamoyltransferases of Escherichia coli. FEBS Lett (1977) 1.23
Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J (1997) 1.22
Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis. Proc Natl Acad Sci U S A (1992) 1.21
Nitric oxide and endothelin secretion by brain microvessel endothelial cells: regulation by cyclic nucleotides. J Cell Physiol (1993) 1.20
Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol (2013) 1.20
Phospholipase A2 enzymes: regulation and inhibition. Trends Pharmacol Sci (1993) 1.20
On the amino-acid sequence of flagellin from Bacillus subtilis 168: comparison with other bacterial flagellins. Proc Natl Acad Sci U S A (1973) 1.19
Atypical beta-adrenergic receptor in 3T3-F442A adipocytes. Pharmacological and molecular relationship with the human beta 3-adrenergic receptor. J Biol Chem (1991) 1.19
"Antibodies raised against beta-adrenergic receptors stimulate adenylate cyclase". Biochem Biophys Res Commun (1981) 1.18
Genetic variation in the stress protein hsp70-2 gene is highly associated with obesity. Int J Obes Relat Metab Disord (2001) 1.17
Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor. Mol Pharmacol (1993) 1.17
Extensive sequence homologies among lectins from leguminous plants. Biochem Biophys Res Commun (1977) 1.17
Leptin receptor gene variation and obesity: lack of association in a white British male population. Hum Mol Genet (1997) 1.16
Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor. Br J Pharmacol (1994) 1.15
Molecular characterization of salt-stress-associated protein in citrus: protein and cDNA sequence homology to mammalian glutathione peroxidases. Plant Mol Biol (1993) 1.15
Antitumor agents. 120. New 4-substituted benzylamine and benzyl ether derivatives of 4'-O-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II. J Med Chem (1991) 1.15
Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. J Pharmacol Exp Ther (1994) 1.14
Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice. Clin Exp Immunol (1992) 1.14
The dependence of acetylcholinesterase aggregation at low ionic strength upon a polyanionic component. Eur J Biochem (1978) 1.14
Collagen-tailed and hydrophobic components of acetylcholinesterase in Torpedo marmorata electric organ. Proc Natl Acad Sci U S A (1980) 1.13
Isolation of adenylate cyclase-free, beta-adrenergic receptor from turkey erythrocyte membranes by affinity chromatography. Proc Natl Acad Sci U S A (1977) 1.13
Purification of recombinant human tissue factor. Biochemistry (1989) 1.13
Characterization, serological specificity, and diagnostic possibilities of monoclonal antibodies against Legionella pneumophila. J Clin Microbiol (1983) 1.12
Substituting selenocysteine for catalytic cysteine 41 enhances enzymatic activity of plant phospholipid hydroperoxide glutathione peroxidase expressed in Escherichia coli. J Biol Chem (2000) 1.12
beta-Adrenergic agonist activity of a monoclonal anti-idiotypic antibody. Proc Natl Acad Sci U S A (1985) 1.11
Evidence for essential disulfide bonds in beta1-adrenergic receptors of turkey erythrocyte membranes. Inactivation by dithiothreitol. J Biol Chem (1979) 1.10
Strategy for the measurement of regional cerebral blood flow using short-lived tracers and emission tomography. J Cereb Blood Flow Metab (1984) 1.09
Cloning and expression of a rat acetylcholinesterase subunit: generation of multiple molecular forms and complementarity with a Torpedo collagenic subunit. J Neurochem (1993) 1.09
Amino-terminal analysis of polypeptide using dimethylaminoazobenzene isothiocyanate. Anal Biochem (1980) 1.09
The production and characterization of antibodies against beta-adrenergic antagonists. Biochem Pharmacol (1978) 1.09
Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. Mol Endocrinol (1999) 1.09
Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma. Mol Cell Endocrinol (2006) 1.08
Acetylcholinesterase H and T dimers are associated through the same contact. Mutations at this interface interfere with the C-terminal T peptide, inducing degradation rather than secretion. J Biol Chem (2001) 1.08
Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. J Biol Chem (1992) 1.08
Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors. Clin Exp Immunol (1989) 1.07
Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan. Hum Pathol (1995) 1.07
Redistribution of muscarinic acetylcholine receptors on human fibroblasts induced by regulatory ligands. Biol Cell (1987) 1.06
Site-directed mutants designed to test back-door hypotheses of acetylcholinesterase function. FEBS Lett (1996) 1.06
Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3'-5'-monophosphate pathway. Biochem Pharmacol (1999) 1.06
Molecular architecture of acetylcholinesterase collagen-tailed forms; construction of a glycolipid-tailed tetramer. EMBO J (1992) 1.05
Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth (1996) 1.05
Expression of three human beta-adrenergic-receptor subtypes in transfected Chinese hamster ovary cells. Eur J Biochem (1991) 1.05
Human beta 2-adrenergic receptors expressed in Escherichia coli membranes retain their pharmacological properties. Proc Natl Acad Sci U S A (1988) 1.05
Effector-dependent conformational changes in protein kinase C gamma through epitope mapping with inhibitory monoclonal antibodies. Eur J Biochem (1990) 1.05
New molecular and structural determinants involved in beta 2-adrenergic receptor desensitization and sequestration. Delineation using chimeric beta 3/beta 2-adrenergic receptors. J Biol Chem (1996) 1.04
N-terminal sequence analysis of polypeptide at the picomole level. Biochem J (1981) 1.04
Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors. J Cereb Blood Flow Metab (1988) 1.04
The leptin receptor promoter controls expression of a second distinct protein. Nucleic Acids Res (1997) 1.04
Localisation of three epitopes of the env protein of feline immunodeficiency virus. Mol Immunol (1992) 1.03
The functional domain of hirudin, a thrombin-specific inhibitor. FEBS Lett (1983) 1.03
Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation. Mol Pharmacol (1999) 1.03
[Electron microscopic studies on stretched and globular acetylcholinesterase molecules of the electric eel (Electrophorus electricus)]. Eur J Biochem (1973) 1.03